We are live on ! Find out more
BRA

Biechele Royce Advisors Portfolio holdings

AUM $303M
1-Year Est. Return 20.64%
This Fund
S&P 500
This Quarter Est. Return
+4.59%
1 Year Est. Return
+20.64%
3 Year Est. Return
+39.24%
5 Year Est. Return
+125.34%
10 Year Est. Return
AUM
$287M
AUM Growth
+$18.2M
Cap. Flow
+$7.95M
Cap. Flow %
2.77%
Top 10 Hldgs %
54.58%
Holding
73
New
8
Increased
32
Reduced
25
Closed
3

Top Buys

Rank Stock Value
1
BNY
Bank of New York Mellon
BNY
+$2.36M
2
CVS icon
CVS Health
CVS
+$1.81M
3
RHI icon
Robert Half
RHI
+$1.8M
4
MDT icon
Medtronic
MDT
+$1.67M
5
PNR icon
Pentair
PNR
+$1.37M

Sector Composition

Rank Sector Weight
1 Technology 24.01%
2 Healthcare 20.72%
3 Industrials 19.56%
4 Financials 11.24%
5 Consumer Discretionary 8.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.95T
$22.4M 7.81%
115,648
-6,202
-5% -$1.08M
AMAT icon
2
Applied Materials
AMAT
$410B
$22.2M 7.72%
153,328
+1,834
+1% +$230K
BWA icon
3
BorgWarner
BWA
$13.1B
$17.6M 6.14%
409,444
+20,504
+5% +$843K
AMGN icon
4
Amgen
AMGN
$203B
$14.7M 5.11%
66,014
+3,293
+5% +$764K
UPS icon
5
United Parcel Service
UPS
$96B
$14.4M 5.03%
80,506
+5,152
+7% +$915K
ON icon
6
ON Semiconductor
ON
$34.7B
$13.7M 4.78%
145,060
-9,322
-6% -$771K
MDT icon
7
Medtronic
MDT
$108B
$13.6M 4.73%
154,129
+19,366
+14% +$1.67M
RHI icon
8
Robert Half
RHI
$4.07B
$13.4M 4.67%
178,080
+25,167
+16% +$1.8M
CVS icon
9
CVS Health
CVS
$137B
$12.9M 4.48%
186,037
+25,508
+16% +$1.81M
BEN icon
10
Franklin Resources
BEN
$17.3B
$11.8M 4.12%
442,875
+33,011
+8% +$853K
BNY
11
Bank of New York Mellon
BNY
$107B
$11.4M 3.96%
255,548
+54,900
+27% +$2.36M
SLV icon
12
iShares Silver Trust
SLV
$28.3B
$10.8M 3.76%
517,122
+1,371
+0.3% +$30.5K
PNR icon
13
Pentair
PNR
$10.2B
$10M 3.5%
155,448
+23,852
+18% +$1.37M
MSM icon
14
MSC Industrial Direct
MSM
$7.07B
$9.34M 3.25%
98,052
-8,057
-8% -$739K
NUE icon
15
Nucor
NUE
$56.4B
$9.09M 3.17%
55,441
-3,331
-6% -$486K
INTC icon
16
Intel
INTC
$462B
$8.58M 2.99%
256,657
+2,863
+1% +$89.9K
ZBH icon
17
Zimmer Biomet
ZBH
$17.8B
$7.74M 2.69%
53,123
+764
+1% +$104K
BMY icon
18
Bristol-Myers Squibb
BMY
$128B
$6.76M 2.35%
105,677
-8,686
-8% -$582K
SCHW
19
Charles Schwab
SCHW
$181B
$6.67M 2.32%
117,589
+870
+0.7% +$45.6K
CAT icon
20
Caterpillar
CAT
$402B
$5.51M 1.92%
22,406
-836
-4% -$186K
SLB icon
21
SLB Ltd
SLB
$76.5B
$4.89M 1.7%
99,593
+14,299
+17% +$682K
WBD icon
22
Warner Bros
WBD
$63.4B
$4.2M 1.46%
335,125
-799
-0.2% -$10.4K
LLY icon
23
Eli Lilly
LLY
$1.07T
$3.65M 1.27%
7,788
-438
-5% -$184K
K
24
DELISTED
Kellanova
K
$3.42M 1.19%
54,069
-3,803
-7% -$243K
ABNB icon
25
Airbnb
ABNB
$87.2B
$2.6M 0.91%
20,322
+30
+0.1% +$3.51K

Similar funds

Biechele Royce Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Biechele Royce Advisors held 73 positions worth $287M, up 6.8% from $269M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Biechele Royce Advisors's Q2 2023 filing shows 8 new, 32 increased, 25 reduced and 3 closed positions. Its largest new stake was Costco: 558 shares worth $301K. The largest sale was Apple, an estimated $1.08M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

  • Biechele Royce Advisors's largest Q2 2023 buy was Costco: 558 shares worth $301K.
  • Biechele Royce Advisors added most to Bank of New York Mellon in Q2 2023, an estimated $2.36M increase.
  • Biechele Royce Advisors's biggest Q2 2023 reduction was Apple, cutting an estimated $1.08M.
  • Biechele Royce Advisors fully exited Canon, Inc. in Q2 2023, selling an estimated $794K.
  • Biechele Royce Advisors's ten largest holdings make up 55% of its $287M portfolio in Q2 2023.
  • Biechele Royce Advisors opened 8 new positions and closed 3 in Q2 2023.
  • Biechele Royce Advisors's portfolio value rose 6.8% quarter-over-quarter to $287M.

Based on Biechele Royce Advisors's 13F filing for Q2 2023, filed 8 Aug 2023.